{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T21:36:50Z","timestamp":1726263410357},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1984,1,1]],"date-time":"1984-01-01T00:00:00Z","timestamp":441763200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1984]]},"DOI":"10.1007\/bf00427781","type":"journal-article","created":{"date-parts":[[2004,11,10]],"date-time":"2004-11-10T09:29:09Z","timestamp":1100078949000},"page":"237-240","source":"Crossref","is-referenced-by-count":12,"title":["Effects of naloxone on methamphetamine and apomorphine stereotypy and on haloperidol catalepsy in rats"],"prefix":"10.1007","volume":"82","author":[{"given":"J. J.","family":"Balsara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. V.","family":"Nandal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. P.","family":"Burte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. H.","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. G.","family":"Chandorkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"511","volume-title":"Neural peptides and neuronal communication","author":"A Agnoli","year":"1980","unstructured":"Agnoli A, Ruggieri S, Falaschi P, Mearelli S, Del Roscio S, D'Urso R, Frajese G (1980) Are the enkephalins involved in Parkinson's diesease? Clinical and neuroendocrine responses to naloxone administration. In: Costa E, Trabucchi M (eds) Neural peptides and neuronal communication. Raven Press, New York, pp 511?521"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.2042-7158.1978.tb13316.x","volume":"30","author":"UMH Al-Shabibi","year":"1978","unstructured":"Al-Shabibi UMH, Doggett NS (1978) On the central noradrenergic mechanism involved in haloperidol-induced catalepsy in the rat. J Pharm Pharmacol 30:529?531","journal-title":"J Pharm Pharmacol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0014-2999(70)90006-3","volume":"11","author":"NE And\u00e9n","year":"1970","unstructured":"And\u00e9n NE, Butcher SG, Corrodi H, Fuxe K, Ungerstedt U (1970) Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol 11:303?314","journal-title":"Eur J Pharmacol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0006-8993(81)91038-6","volume":"222","author":"AFT Arnsten","year":"1981","unstructured":"Arnsten AFT, Segal DS, Loughlin SE, Roberts DCS (1981) Evidence for an interaction of opioid and noradrenergic locus coeruleus systems in the regulation of environmental stimulus-directed behavior. Brain Res 222:351?363","journal-title":"Brain Res"},{"key":"CR5","first-page":"475","volume-title":"The pharmacological basis of therapeutics","author":"JR Bianchine","year":"1980","unstructured":"Bianchine JR (1980) Drugs for Parkinson's disease; centrally acting muscle relaxants. In: Gilman AG, Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics. Macmillan Publishing Co, New York, pp 475?493"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF00427638","volume":"69","author":"N Bj\u00f8rndal","year":"1980","unstructured":"Bj\u00f8rndal N, Casey DE, Gerlach J (1980) Enkephalin, morphine, and naloxone in tardive dyskinesia. Psychopharmacology 69:133?136","journal-title":"Psychopharmacology"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00431741","volume":"51","author":"C Braestrup","year":"1977","unstructured":"Braestrup C (1977) Changes in drug-induced stereotyped behaviour after 6-OHDA lesions in noradrenaline neurons. Psychopharmacology 51:199?204","journal-title":"Psychopharmacology"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1600-0773.1963.tb01730.x","volume":"20","author":"A Carlsson","year":"1963","unstructured":"Carlsson A, Lindqvist M (1963) Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol (Kbh) 20:140?144","journal-title":"Acta Pharmacol Toxicol (Kbh)"},{"key":"CR9","first-page":"217","volume-title":"The endorphins","author":"E Costa","year":"1978","unstructured":"Costa E, Fratta W, Hong JS, Moroni F, Yang HYT (1978) Interactions between enkephalinergic and other neuronal systems. In: Costa E, Trabucchi M (eds) The endorphins. Raven Press, New York, pp 217?226"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0014-2999(74)90201-5","volume":"27","author":"B Costall","year":"1974","unstructured":"Costall B, Naylor RJ (1974a) Mesolimbic involvement with behavioural effects indicating antipsychotic activity. Eur J Pharmacol 27:46?58","journal-title":"Eur J Pharmacol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF00421964","volume":"34","author":"B Costall","year":"1974","unstructured":"Costall B, Naylor RJ (1974b) On catalepsy and catatonia and the predictability of the catalepsy test for neuroleptic activity. Psychopharmacologia 34:233?241","journal-title":"Psychopharmacologia"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0006-8993(75)90834-3","volume":"83","author":"I Creese","year":"1975","unstructured":"Creese I, Iversen SD (1975) The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res 83:419?436","journal-title":"Brain Res"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/0024-3205(78)90360-0","volume":"22","author":"A Czlonkowski","year":"1978","unstructured":"Czlonkowski A, H\u00f6llt V, Herz A (1978) Binding of opiates and endogenous opioid peptides to neuroleptic receptor sites in the corpus striatum. Life Sci 22:953?962","journal-title":"Life Sci"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0014-2999(78)90369-2","volume":"47","author":"R Dingledine","year":"1978","unstructured":"Dingledine R, Iversen LL, Breuker E (1978) Naloxone as a GABA antagonist: evidence from iontophoretic, receptor binding and convulsant studies. Eur J Pharmacol 47:19?27","journal-title":"Eur J Pharmacol"},{"key":"CR15","first-page":"155","volume-title":"Dopaminergic mechanisms","author":"O Hornykiewicz","year":"1975","unstructured":"Hornykiewicz O (1975) Parkinsonism induced by dopaminergic antagonists. In: Calne DB, Chase TN, Barbeau A (eds) Dopaminergic mechanisms. Raven Press, New York, pp 155?164"},{"key":"CR16","first-page":"494","volume-title":"The pharmacological basis of therapeutics","author":"JH Jaffe","year":"1980","unstructured":"Jaffe JH, Martin WR (1980) Opioid analgesics and antagonists. In: Gilman AG, Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics. Macmillan Publishing Co, New York, pp 494?534"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0140-6736(79)91426-0","volume":"I","author":"A Jorgensen","year":"1979","unstructured":"Jorgensen A, Fog R, Veilis B (1979) Synthetic enkephalin analogue in treatment of schizophrenia. Lancet I:935","journal-title":"Lancet"},{"key":"CR18","first-page":"1","volume-title":"Clinical neuropharmacology, vol 1","author":"HL Klawans","year":"1976","unstructured":"Klawans HL, Goetz C, Westheimer R (1976) The pharmacology of schizophrenia. In: Klawans HL (ed) Clinical neuropharmacology, vol 1 Raven Press, New York, pp 1?28"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0014-2999(77)90025-5","volume":"43","author":"JE Leysen","year":"1977","unstructured":"Leysen JE, Tollenaere JP, Koch MHJ, Laduron P (1977) Differentiation of opiate and neuroleptic receptor binding in rat brain. Eur J Pharmacol 43:253?267","journal-title":"Eur J Pharmacol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/264567a0","volume":"264","author":"HH Loh","year":"1976","unstructured":"Loh HH, Brase DA, Sampath-Khanna S, Mar JB, Way EL, Li CH (1976) ?-Endorphin in vitro inhibition of striatal dopamine release. Nature 264:567?568","journal-title":"Nature"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00429179","volume":"60","author":"ST Mason","year":"1978","unstructured":"Mason ST, Roberts DCS, Fibiger HC (1978) Noradrenergic influences on catalepsy. Psychopharmacology 60:53?57","journal-title":"Psychopharmacology"},{"key":"CR22","first-page":"860","volume":"38","author":"BH Moon","year":"1979","unstructured":"Moon BH, Feigenbaum JJ, Klawans HL (1979) Naloxone enhancement of amphetamine-induced dopamine release. Fed Proc 38:860","journal-title":"Fed Proc"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/0024-3205(81)90318-0","volume":"28","author":"MM Namba","year":"1981","unstructured":"Namba MM, Quock RM, Malone MH (1981) Effects of narcotic antagonists on l-dopa reversal of reserpine-induced catalepsy and blepharoptosis in mice. Life Sci 28:1629?1636","journal-title":"Life Sci"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0028-3908(77)90023-5","volume":"16","author":"SJ Peroutka","year":"1977","unstructured":"Peroutka SJ, U'Prichard DC, Greenberg DA, Snyder SH (1977) Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain. Neuropharmacology 16:549?556","journal-title":"Neuropharmacology"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0304-3940(78)90216-1","volume":"7","author":"H Pollard","year":"1977","unstructured":"Pollard H, Llorens C, Bonnet JJ, Costentin J, Schwartz JC (1977a) Opiate receptors on mesolimbic dopaminergic neurons. Neurosci Letters 7:295?299","journal-title":"Neurosci Letters"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/268745a0","volume":"268","author":"H Pollard","year":"1977","unstructured":"Pollard H, Llorens-Cortes C, Schwartz JC (1977b) Enkephalin receptors on dopaminergic neurones in rat striatum. Nature 268:745?747","journal-title":"Nature"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/0006-8993(78)90895-8","volume":"151","author":"H Pollard","year":"1978","unstructured":"Pollard H, Llorens C, Schwartz JC, Gros C, Dray F (1978) Localization of opiate receptors and enkephalins in the rat striatum in relationship with the nigrostriatal dopaminergic system: lesion studies. Brain Res 151:392?398","journal-title":"Brain Res"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00510981","volume":"298","author":"C Pycock","year":"1977","unstructured":"Pycock C (1977) Noradrenergic involvement in dopamine dependent stereotyped and cataleptic responses in the rat. Naunyn-Schmiedeberg's Arch Pharmacol 298:15?22","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR29","first-page":"323","volume-title":"Dopamine","author":"CJ Pycock","year":"1978","unstructured":"Pycock CJ, Horton RW, Carter CJ (1978) Interactions of 5-hydroxytryptamine and ?-aminobutyric acid with dopamine. In: Roberts PJ, Woodruff GN, Iversen LL (eds) Dopamine. Raven Press, New York, pp 323?341"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0014-2999(77)90202-3","volume":"41","author":"M Raiteri","year":"1977","unstructured":"Raiteri M, Del Carmine R, Bertollini A, Levi G (1977) Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine. Eur J Pharmacol 41:133?143","journal-title":"Eur J Pharmacol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-3956(74)90062-4","volume":"11","author":"A Randrup","year":"1974","unstructured":"Randrup A, Munkvad I (1974) Pharmacology and physiology of stereotyped behaviour. J Psychiatr Res 11:1?10","journal-title":"J Psychiatr Res"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1176\/ajp.135.12.1569-a","volume":"135","author":"SH Snyder","year":"1978","unstructured":"Snyder SH (1978) The opiate receptor and morphine-like peptides in the brain. Am J Psychiatry 135:645?652","journal-title":"Am J Psychiatry"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev.ne.02.030179.000343","volume":"2","author":"SH Snyder","year":"1979","unstructured":"Snyder SH, Childers SR (1979) Opiate receptors and opioid peptides. Ann Rev Neurosci 2:35?64","journal-title":"Ann Rev Neurosci"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF00498558","volume":"299","author":"N Subramanian","year":"1977","unstructured":"Subramanian N, Mitznegg P, Spruegel W, Domschke W, Domschke S, Wunsch E, Demling L (1977) Influence of enkephalin on K+ evoked efflux of putative neurotransmitters in rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 299:163?165","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR35","first-page":"241","volume-title":"Neuropsychopharmacology of monoamines and their regulatory enzymes","author":"MB Wallach","year":"1974","unstructured":"Wallach MB (1974) Drug-induced stereotyped behaviour: Similarities and differences. In: Usdin E (ed) Neuropsychopharmacology of monoamines and their regulatory enzymes. Raven Press, New York, pp 241?260"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.2042-7158.1978.tb13372.x","volume":"30","author":"P Worms","year":"1978","unstructured":"Worms P, Willigens MT, Lloyd KG (1978) GABA involvement in neuroleptic-induced catalepsy. J Pharm Pharmacol 30:716?718","journal-title":"J Pharm Pharmacol"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0028-3908(81)90116-7","volume":"20","author":"G Zetler","year":"1981","unstructured":"Zetler G (1981) Differential cataleptogenic and antistereotypic effects of caerulein and haloperidol. Neuropharmacology 20:681?686","journal-title":"Neuropharmacology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00427781.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00427781\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00427781","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T22:37:52Z","timestamp":1554849472000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00427781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1984]]}},"alternative-id":["BF00427781"],"URL":"https:\/\/doi.org\/10.1007\/bf00427781","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984]]}}}